Last reviewed · How we verify
Trichosanthes root — Competitive Intelligence Brief
marketed
Oncology
Small molecule
Live · refreshed every 30 min
Target snapshot
Trichosanthes root (Trichosanthes root) — China Medical University Hospital. Trichosanthes root contains bioactive compounds that exhibit anti-inflammatory, immunomodulatory, and potential antitumor properties through multiple cellular pathways.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Trichosanthes root TARGET | Trichosanthes root | China Medical University Hospital | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Trichosanthes root CI watch — RSS
- Trichosanthes root CI watch — Atom
- Trichosanthes root CI watch — JSON
- Trichosanthes root alone — RSS
Cite this brief
Drug Landscape (2026). Trichosanthes root — Competitive Intelligence Brief. https://druglandscape.com/ci/trichosanthes-root. Accessed 2026-05-14.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab